S&P 500   4,966.81 (-0.88%)
DOW   37,990.25 (+0.57%)
QQQ   414.07 (-2.21%)
AAPL   164.99 (-1.23%)
MSFT   398.16 (-1.51%)
META   476.40 (-5.06%)
GOOGL   153.28 (-1.75%)
AMZN   173.54 (-3.17%)
TSLA   146.63 (-2.20%)
NVDA   760.13 (-10.23%)
AMD   146.23 (-5.71%)
NIO   3.79 (-5.25%)
BABA   68.94 (+0.09%)
T   16.49 (+0.98%)
F   12.10 (+0.33%)
MU   106.21 (-5.11%)
GE   148.09 (-3.17%)
CGC   7.97 (+1.79%)
DIS   112.24 (-0.17%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.93 (+1.19%)
S&P 500   4,966.81 (-0.88%)
DOW   37,990.25 (+0.57%)
QQQ   414.07 (-2.21%)
AAPL   164.99 (-1.23%)
MSFT   398.16 (-1.51%)
META   476.40 (-5.06%)
GOOGL   153.28 (-1.75%)
AMZN   173.54 (-3.17%)
TSLA   146.63 (-2.20%)
NVDA   760.13 (-10.23%)
AMD   146.23 (-5.71%)
NIO   3.79 (-5.25%)
BABA   68.94 (+0.09%)
T   16.49 (+0.98%)
F   12.10 (+0.33%)
MU   106.21 (-5.11%)
GE   148.09 (-3.17%)
CGC   7.97 (+1.79%)
DIS   112.24 (-0.17%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.93 (+1.19%)
S&P 500   4,966.81 (-0.88%)
DOW   37,990.25 (+0.57%)
QQQ   414.07 (-2.21%)
AAPL   164.99 (-1.23%)
MSFT   398.16 (-1.51%)
META   476.40 (-5.06%)
GOOGL   153.28 (-1.75%)
AMZN   173.54 (-3.17%)
TSLA   146.63 (-2.20%)
NVDA   760.13 (-10.23%)
AMD   146.23 (-5.71%)
NIO   3.79 (-5.25%)
BABA   68.94 (+0.09%)
T   16.49 (+0.98%)
F   12.10 (+0.33%)
MU   106.21 (-5.11%)
GE   148.09 (-3.17%)
CGC   7.97 (+1.79%)
DIS   112.24 (-0.17%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.93 (+1.19%)
S&P 500   4,966.81 (-0.88%)
DOW   37,990.25 (+0.57%)
QQQ   414.07 (-2.21%)
AAPL   164.99 (-1.23%)
MSFT   398.16 (-1.51%)
META   476.40 (-5.06%)
GOOGL   153.28 (-1.75%)
AMZN   173.54 (-3.17%)
TSLA   146.63 (-2.20%)
NVDA   760.13 (-10.23%)
AMD   146.23 (-5.71%)
NIO   3.79 (-5.25%)
BABA   68.94 (+0.09%)
T   16.49 (+0.98%)
F   12.10 (+0.33%)
MU   106.21 (-5.11%)
GE   148.09 (-3.17%)
CGC   7.97 (+1.79%)
DIS   112.24 (-0.17%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.93 (+1.19%)

Fusion Antibodies (FAB) News Today

GBX 3.80
+0.05 (+1.33%)
(As of 04:29 PM ET)
SourceHeadline
msn.com logoResearch Reveals Conserved Neutralizing Epitope in Herpesvirus gB Protein
msn.com - February 27 at 8:42 AM
uk.investing.com logoFusion Antibodies PLC (FAB)
uk.investing.com - February 22 at 8:11 AM
lse.co.uk logoFusion Antibodies gets tax credit from UK HMRC for OptiMAL platform
lse.co.uk - February 2 at 8:09 PM
lse.co.uk logoFusion Antibody Share Chat
lse.co.uk - January 22 at 4:06 PM
msn.com logoHIV antibodies protect animals in proof-of-concept study
msn.com - January 17 at 7:31 PM
morningstar.com logoFusion Antibodies PLC Ordinary Shares FAB
morningstar.com - January 9 at 10:14 AM
msn.com logoStudy suggests omicron subvariant causes enhanced fusion with human lung cells
msn.com - January 8 at 1:35 PM
markets.businessinsider.com logoFusion's Pharma's Targeted Cancer Therapy Potential Gets This Analyst Bullish, Sees 100% Upside
markets.businessinsider.com - December 20 at 3:20 PM
marketwatch.com logoFusion Antibodies Shares Rise on US Cancer Institute Collaboration
marketwatch.com - November 28 at 8:30 AM
msn.com logoBelfast antibodies firm Fusion flags up 'challenges'
msn.com - November 9 at 9:51 AM
news.yahoo.com logoNew cancer therapy using antibody could offer a less toxic treatment option, study shows
news.yahoo.com - October 31 at 3:54 PM
finance.yahoo.com logoFusion Antibodies Full Year 2023 Earnings: UK£0.10 loss per share (vs UK£0.046 loss in FY 2022)
finance.yahoo.com - October 1 at 5:56 AM
marketwatch.com logoFusion Antibodies Pretax Loss Widens on Higher Costs, Lower Revenue
marketwatch.com - September 29 at 1:33 PM
markets.businessinsider.com logoIntroducing NeoMab™: GemPharmatech's Innovative Antibody Gene Humanized Mouse Model
markets.businessinsider.com - August 23 at 6:38 AM
marketwatch.com logoFusion Antibodies Signs Combined Screening Service With AI Company
marketwatch.com - August 21 at 5:16 AM
finance.yahoo.com logoTonix Pharmaceuticals Initiates Phase 1 Trial of TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers
finance.yahoo.com - August 16 at 8:06 AM
marketwatch.com logoFusion Antibodies Shares Dive After Discounted Placing
marketwatch.com - May 19 at 9:39 AM
marketwatch.com logoAntibody Engineering Services Market Growth, Business Overview 2023, and Forecast to 2030 | Fusion Antibodies, Absolute Antibody, Creative Biolabs
marketwatch.com - May 16 at 4:50 PM
forbes.com logoResurrection Of Covid Antibody Therapy: IgG3 Fc Fusion To The Rescue
forbes.com - April 28 at 3:32 PM
marketwatch.com logoAntibody Engineering Services Market Growth by 2031
marketwatch.com - April 27 at 7:34 PM
marketwatch.com logoAntibody Engineering Services Market Projected Industry Expansion and Factors Impacting Competitors, Alongside Promising Strategies Until 2029
marketwatch.com - April 20 at 11:34 PM
marketwatch.com logoRecombinant Therapeutic Antibodies and Proteins Market: Key Players and Strategies for Future Growth by 2023-2030
marketwatch.com - April 19 at 10:56 PM
msn.com logoFusion (FUSN) to Begin Clinical Study on Targeted Alpha Therapy
msn.com - April 13 at 3:09 PM
marketwatch.com logoFusion Antibodies Files Patent Application for Cancer Treatment Antibodies
marketwatch.com - March 21 at 7:50 AM
foxnews.com logoSleep deprivation could reduce vaccine antibodies, new study found
foxnews.com - March 15 at 9:18 PM
marketwatch.com logoFusion Antibodies Sees Lower FY 2023 Revenue On Order Delays
marketwatch.com - March 6 at 5:40 AM
marketwatch.com logoIn Depth Research on Recombinant Therapeutic Antibodies and Proteins Market Report 2023-2029
marketwatch.com - March 1 at 12:46 PM
marketwatch.com logoAntibody Engineering Services Market | Rising Sales of the Industry Are Set To Drive for Growth Prospects and Innovations
marketwatch.com - February 6 at 11:32 PM
forbes.com logoBivalent Antibodies For Covid-19: Two Hands Are Better Than One
forbes.com - January 21 at 11:26 PM
finance.yahoo.com logoCancer Monoclonal Antibodies Market Report 2022: Rising Preference for Personalized Medicines Provides Boost to Sector
finance.yahoo.com - November 28 at 7:40 PM
forbes.com logoNew Monoclonal Antibody Cocktail Neutralizes Lassa Virus
forbes.com - November 3 at 2:32 PM
forbes.com logoAs Protection From Current Covid-19 Monoclonal Antibody Treatments Fades, The Discovery Of A New Class Of Antibodies Brings Hope
forbes.com - October 27 at 5:11 PM
marketwatch.com logoRecombinant Therapeutic Antibodies and Proteins Market 2022 Giants Spending Is Going To Boom In 2028
marketwatch.com - October 21 at 8:00 AM
time.com logoThe New Bivalent Booster Increases Antibodies to Fight Omicron, Data Show
time.com - October 18 at 8:34 AM
abcnews.go.com logo86% of kids under 17 have antibodies from a past COVID infection, CDC data shows
abcnews.go.com - October 10 at 10:10 AM
marketwatch.com logoDiagnostic Specialty Antibodies Market Size And Opportunities for New Players, Forecast from 2022 To 2028
marketwatch.com - September 20 at 8:30 PM
uk.finance.yahoo.com logoFusion Antibodies Plc (FAB.L)
uk.finance.yahoo.com - September 12 at 11:57 PM
forbes.com logoProgress In The Search For Broadly Neutralizing Monoclonal Antibodies VII
forbes.com - September 7 at 10:33 PM
forbes.com logoProgress In The Search For Broadly Neutralizing Monoclonal Antibodies VI
forbes.com - September 1 at 11:23 AM
finance.yahoo.com logoFusion Pharmaceuticals Announces First Patient Dosed in Phase 1/2 Study of FPI-1966 In Patients with Advanced Solid Tumors Expressing FGFR3
finance.yahoo.com - August 29 at 9:54 AM
lse.co.uk logoFusion Antibodies sees revenue growth on transient expression service
lse.co.uk - August 24 at 9:22 PM
marketwatch.com logoFusion Antibodies FY 2022 Pretax Loss Widened Slightly; Revenue Rose
marketwatch.com - August 23 at 9:54 AM
duluthnewstribune.com logoMayo study finds new monoclonal antibody is effective against omicron variants
duluthnewstribune.com - August 18 at 10:44 PM
forbes.com logoProgress In The Search For Broadly Neutralizing Monoclonal Antibodies V
forbes.com - August 1 at 10:52 AM
marketwatch.com logoFusion Antibodies Appoints Adrian Kinkaid CEO Effective Aug. 15
marketwatch.com - July 28 at 7:11 AM
tmcnet.com logoDyadic to Participate in Three Upcoming Industry Events
tmcnet.com - June 9 at 12:53 PM
apnews.com logoSpecifica Announces Antibody Discovery Platform Transfer Agreement with Sanofi
apnews.com - June 2 at 6:30 PM
finance.yahoo.com logoDyadic to Present at 2022 Jefferies Healthcare Conference
finance.yahoo.com - June 2 at 6:30 PM
lse.co.uk logoFusion Antibodies annual revenue grows despite challenges
lse.co.uk - May 6 at 7:15 AM
marketwatch.com logoFusion Antibodies FY 2022 Revenue Rose 14%
marketwatch.com - May 6 at 7:15 AM
Get Fusion Antibodies News Delivered to You Automatically

Sign up to receive the latest news and ratings for FAB and its competitors with MarketBeat's FREE daily newsletter.

Strange new buyer driving up gold (Ad)

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

FAB Media Mentions By Week

FAB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FAB
News Sentiment

0.00

0.52

Average
Medical
News Sentiment

FAB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FAB Articles
This Week

0

0

FAB Articles
Average Week

Get Fusion Antibodies News Delivered to You Automatically

Sign up to receive the latest news and ratings for FAB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (LON:FAB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners